Penn Dermatology sponsors and partners with several core facilities and centers to advance basic research, translational research and clinical applications of cutaneous diseases.
Autoimmune Skin Disease Clinical Studies Group
The Autoimmune Skin Disease Clinical Studies Group investigates autoimmune diseases including cutaneous lupus, dermatomyositis, scleroderma and autoimmune blistering diseases. The group actively engages in basic and translational research, including clinical trials. Its core missions are clinical care, research and training in this area.
Center for DermatoEpidemiology and Translation (CDET)
The mission of the Center for DermatoEpidemiology and Translation (CDET), directed by David Margolis, MD, PhD, is to become the world's leading center focusing on cutaneous epidemiological research and clinical evaluation aspects of translational research. CDET serves as the intellectual home for established faculty, new faculty and trainees. CDET is an interdepartmental home for investigators from many disciplines who are interested in cutaneous diseases including: infectious disease, pediatrics, allergy and pulmonology, autoimmune disease, cardiovascular disease, international medicine, regenerative medicine, cancer biology, surgical oncology and of course, dermatology.
Dermatology Clinical Effectiveness Research Network (DCERN)
The Dermatology Clinical Effectiveness Research Network (DCERN) is a partnership of dermatology practices across the United States that performs scientifically sound clinical research critical to advancing the care of dermatologic disorders. Current DCERN comparative studies assist physicians with making informed treatment decisions and improve the quality of care for patients with moderate to severe psoriasis. The principal investigator of DCERN is Joel M. Gelfand, MD, MSCE.